GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/6/2026 5:03:28 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $183,903,000 +5.4% | Assets $1,743,766,000 | EPS $0.67 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/6/2026 4:53:45 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $183,903,000 +5.4% | Assets $1,743,766,000 | EPS $0.67 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/7/2026 4:51:24 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $171,171,000 +0.4% | Assets $1,648,162,000 | EPS $0.14 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/7/2026 4:29:58 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $171,171,000 +0.4% | Assets $1,648,162,000 | EPS $0.14 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/13/2026 4:19:57 PM | View | Proxy | SEC | Y 2025 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/26/2026 4:55:39 PM | Mid | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $719,887,000 -1.7% | Assets $1,629,299,000 | EPS $2.03 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/26/2026 4:30:03 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $183,105,000 -1.8% | Assets $1,629,299,000 | EPS $0.51 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/6/2025 4:45:42 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $191,840,000 +0.3% | Assets $1,666,222,000 | EPS $0.37 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/6/2025 4:33:57 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $191,840,000 +0.3% | Assets $1,666,222,000 | EPS $0.37 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/7/2025 4:56:39 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $174,414,000 -4.4% | Assets $1,615,333,000 | EPS $0.64 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/7/2025 4:34:04 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $174,414,000 -4.4% | Assets $1,615,333,000 | EPS $0.64 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/8/2025 4:34:35 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $170,528,000 -0.8% | Assets $1,626,276,000 | EPS $0.51 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/7/2025 4:25:46 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $170,528,000 -0.8% | Assets $1,626,276,000 | EPS $0.51 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/14/2025 4:10:37 PM | View | Proxy | SEC | Y 2024 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/3/2025 4:24:33 PM | Mid | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $731,967,000 +13.6% | Assets $1,577,470,000 | EPS $3.06 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/27/2025 4:38:05 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $186,523,000 +4.7% | Assets $1,577,470,000 | EPS $0.74 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/7/2024 4:34:50 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $191,214,000 +5.9% | Assets $1,545,178,000 | EPS $0.78 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/6/2024 4:43:19 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $191,214,000 +5.9% | Assets $1,545,178,000 | EPS $0.78 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2024 4:28:12 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $182,394,000 +25.2% | Assets $1,491,522,000 | EPS $0.73 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/7/2024 4:33:17 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $182,394,000 +25.2% | Assets $1,491,522,000 | EPS $0.73 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2024 6:19:30 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $171,836,000 +22.7% | Assets $1,574,317,000 | EPS $0.81 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/8/2024 4:23:24 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $171,836,000 +22.7% | Assets $1,574,317,000 | EPS $0.81 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/12/2024 4:10:17 PM | View | Proxy | SEC | Y 2023 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/29/2024 4:52:00 PM | Mid | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $644,395,000 +29.1% | Assets $1,512,912,000 | EPS $2.60 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/28/2024 4:46:53 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $178,105,000 +31.9% | Assets $1,512,912,000 | EPS $0.69 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2023 4:34:59 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $180,556,000 +50.3% | Assets $1,544,633,000 | EPS $0.91 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2023 4:16:27 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $180,556,000 +50.3% | Assets $1,544,633,000 | EPS $0.91 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2023 6:15:18 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $145,712,000 +18.0% | Assets $1,378,266,000 | EPS $0.49 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/8/2023 4:38:51 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $145,712,000 +18.0% | Assets $1,378,266,000 | EPS $0.49 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2023 5:00:35 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $140,022,000 +16.3% | Assets $773,656,000 | EPS $0.50 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2023 4:21:14 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $140,022,000 +16.3% | Assets $773,656,000 | EPS $0.50 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/14/2023 4:11:31 PM | View | Proxy | SEC | Y 2022 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/1/2023 4:26:19 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $498,987,000 +14.0% | Assets $741,987,000 | EPS $1.74 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2/28/2023 4:25:43 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $135,023,000 +11.7% | Assets $741,987,000 | EPS $0.65 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2022 6:18:21 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $120,129,000 +7.1% | Assets $726,695,000 | EPS $0.30 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/7/2022 4:22:33 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $120,129,000 +7.1% | Assets $726,695,000 | EPS $0.30 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2022 6:16:09 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $123,467,000 +21.4% | Assets $723,719,000 | EPS $0.33 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/8/2022 4:25:18 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $123,467,000 +21.4% | Assets $723,719,000 | EPS $0.33 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2022 6:21:16 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $120,368,000 +16.8% | Assets $716,238,000 | EPS $0.47 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2022 4:28:38 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $120,368,000 +16.8% | Assets $716,238,000 | EPS $0.47 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/14/2022 4:28:31 PM | View | Proxy | SEC | Y 2021 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/11/2022 4:22:00 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $437,768,000 +25.1% | Assets $671,529,000 | EPS $1.25 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/10/2022 4:20:35 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $120,887,000 +26.0% | Assets $671,529,000 | EPS $0.40 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/9/2021 6:14:25 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $112,198,000 +34.5% | Assets $651,677,000 | EPS $0.59 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2021 4:37:44 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $112,198,000 +34.5% | Assets $651,677,000 | EPS $0.59 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2021 4:44:19 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $101,663,000 +18.5% | Assets $665,745,000 | EPS $0.16 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2021 4:30:15 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $101,663,000 +18.5% | Assets $665,745,000 | EPS $0.16 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/7/2021 4:32:25 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $103,020,000 +21.6% | Assets $645,738,000 | EPS $0.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/6/2021 4:27:05 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $103,020,000 +21.6% | Assets $645,738,000 | EPS $0.10 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/14/2021 4:11:02 PM | View | Proxy | SEC | Y 2020 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/15/2021 4:31:24 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $349,846,000 +8.5% | Assets $631,236,000 | EPS $0.03 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/15/2021 4:15:45 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $95,921,000 +15.0% | Assets $631,236,000 | EPS -$0.13 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/6/2020 4:24:06 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $83,431,000 +4.1% | Assets $613,718,000 | EPS $0.08 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/6/2020 7:01:47 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $83,431,000 +4.1% | Assets $613,718,000 | EPS $0.08 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/10/2020 6:13:19 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $85,806,000 +8.6% | Assets $600,058,000 | ||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/6/2020 4:23:33 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $85,806,000 +8.6% | Assets $600,058,000 | Export Earnings Model | ||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/11/2020 4:26:31 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $84,688,000 +6.1% | Assets $572,831,000 | EPS $0.08 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/7/2020 4:40:20 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $84,688,000 +6.1% | Assets $572,831,000 | EPS $0.08 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/15/2020 4:31:47 PM | View | Proxy | SEC | Y 2019 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/16/2020 5:03:46 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $322,357,000 +9.4% | Assets $586,971,000 | EPS $0.98 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/12/2020 4:19:49 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $83,383,000 -7.0% | Assets $586,971,000 | EPS -$0.02 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2019 5:19:44 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $80,137,000 +6.1% | Assets $585,636,000 | EPS $0.03 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/7/2019 4:36:35 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $80,137,000 +6.1% | Assets $585,636,000 | EPS $0.03 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2019 6:12:32 AM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $79,047,000 +11.3% | Assets $601,301,000 | EPS $0.96 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/7/2019 4:35:59 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $79,047,000 +11.3% | Assets $601,301,000 | EPS $0.96 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2019 6:25:24 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $79,790,000 +36.6% | Assets $544,718,000 | EPS $0.02 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2019 4:40:54 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $79,790,000 +36.6% | Assets $544,718,000 | EPS $0.02 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/18/2019 4:13:11 PM | View | Proxy | SEC | Y 2018 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/15/2019 6:39:29 AM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $294,666,000 +22.7% | Assets $513,563,000 | EPS -$0.12 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/12/2019 4:22:41 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $89,690,000 +48.5% | Assets $513,563,000 | EPS $0.04 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/9/2018 6:12:43 AM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $75,543,000 +30.4% | Assets $480,642,000 | EPS $0.05 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2018 4:33:01 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $75,543,000 +30.4% | Assets $480,642,000 | EPS $0.05 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2018 6:13:45 AM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $71,040,000 +9.0% | Assets $451,646,000 | EPS -$0.06 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/8/2018 4:27:43 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $71,040,000 +9.0% | Assets $451,646,000 | EPS -$0.06 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2018 6:12:29 AM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $58,393,000 +3.0% | Assets $449,782,000 | EPS -$0.15 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2018 5:08:36 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $58,393,000 +3.0% | Assets $449,782,000 | EPS -$0.15 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/18/2018 4:11:19 PM | View | Proxy | SEC | Y 2017 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/14/2018 6:14:44 AM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $240,175,000 -5.9% | Assets $451,072,000 | EPS $0.08 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/12/2018 4:25:12 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $60,402,000 -4.9% | Assets $451,072,000 | EPS $0.02 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/9/2017 6:16:12 AM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $57,916,000 -9.8% | Assets $437,766,000 | ||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2017 4:27:08 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $57,916,000 -9.8% | Assets $437,766,000 | Export Earnings Model | ||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2017 5:34:33 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $65,187,000 -4.2% | Assets $443,997,000 | EPS $0.04 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2017 4:18:28 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $65,187,000 -4.2% | Assets $443,997,000 | EPS $0.04 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2017 6:16:25 AM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $56,670,000 -4.5% | Assets $435,612,000 | EPS $0.02 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/8/2017 4:25:51 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $56,670,000 -4.5% | Assets $435,612,000 | EPS $0.02 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/21/2017 4:10:13 PM | View | Proxy | SEC | Y 2016 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/15/2017 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $255,165,000 +1.4% | Assets $427,738,000 | EPS $0.21 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/13/2017 4:35:59 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $63,543,000 -17.4% | Assets $427,738,000 | EPS -$0.06 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/9/2016 6:31:19 AM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $64,223,000 +0.6% | Assets $428,837,000 | EPS $0.08 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/8/2016 4:22:30 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $64,223,000 +0.6% | Assets $428,837,000 | EPS $0.08 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/9/2016 6:07:27 AM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $68,033,000 +26.3% | Assets $408,586,000 | EPS $0.15 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/8/2016 4:24:56 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $68,033,000 +26.3% | Assets $408,586,000 | EPS $0.15 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/10/2016 6:22:50 AM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $59,366,000 +4.4% | Assets $395,006,000 | EPS $0.05 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/9/2016 4:18:27 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $59,366,000 +4.4% | Assets $395,006,000 | EPS $0.05 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/22/2016 4:02:00 PM | View | Proxy | SEC | Y 2015 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/15/2016 2:08:18 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $251,519,000 +19.5% | Assets $390,136,000 | EPS -$0.06 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/14/2016 4:11:27 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $76,912,000 +37.6% | Assets $390,136,000 | EPS $0.16 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/13/2015 6:07:52 AM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $63,868,000 +7.0% | Assets $395,027,000 | EPS -$0.07 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/12/2015 4:12:15 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $63,868,000 +7.0% | Assets $395,027,000 | EPS -$0.07 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/13/2015 4:00:44 PM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $53,853,000 +9.9% | Assets $398,929,000 | EPS -$0.15 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/12/2015 4:05:16 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $53,853,000 +9.9% | Assets $398,929,000 | EPS -$0.15 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/14/2015 6:00:48 AM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $56,886,000 +24.0% | Assets $396,502,000 | EPS -$0.01 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 5/13/2015 6:02:17 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $56,886,000 +24.0% | Assets $396,502,000 | EPS -$0.01 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 4/8/2015 4:00:26 PM | View | Proxy | SEC | Y 2014 | ||||||
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/26/2015 6:10:49 AM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $210,461,000 -8.4% | Assets $389,370,000 | EPS -$0.25 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 3/24/2015 4:05:16 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $55,877,000 +1.8% | Assets $389,370,000 | EPS -$0.06 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/13/2014 4:19:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $59,711,000 +0.7% | Assets $401,133,000 | EPS -$0.12 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 11/12/2014 4:13:11 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $59,711,000 +0.7% | Assets $401,133,000 | EPS -$0.12 | Export Earnings Model | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/13/2014 4:17:50 PM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $49,003,000 -21.6% | Assets $397,268,000 | EPS -$0.03 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 8/12/2014 4:02:13 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $49,003,000 -21.6% | Assets $397,268,000 | EPS -$0.03 | Export Earnings Model |